Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03056755 |
|---|---|
| Brief Title: | Study Assessing the Efficacy and Safety of Alpelisib Plus Fulvestrant or Letrozole, Based on Prior Endocrine Therapy, in Patients With PIK3CA Mutation With Advanced Breast Cancer Who Have Progressed on or After Prior Treatments (BYLieve) |
| First Submitted : | February 15, 2017 |
| First Submitted that Met QC Criteria : | February 15, 2017 |
| First Posted : | February 17, 2017 |
| Last Update Submitted that Met QC Criteria : | August 1, 2019 |
| Last Update Posted : | August 5, 2019 |